your badges 52W Range $12–$30 91% of range Analyst Rating BUY 14 analysts Price Target $27 P/E -70.9 ROE -39.6% Net Profit Margin -20.7%

ADPT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $28.35
Market Cap (MRQ) $4.51B
P/E (TTM) -70.9
EPS (TTM) $-0.40
Revenue (TTM) $308M
ROE (TTM) -39.6%
Debt/Equity (MRQ) 0.0
52W Range $12–$30

ADPT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Adaptive Biotechnologies Corporation - Common Stock Company overview from Wikipedia

05 · wikidata
sectorHealthcare industryLife Sciences Tools & Services employees624 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$277M
2017-12-31 → 2025-12-31
EPS$-0.39
2020-12-31 → 2025-12-31
Free Cash Flow$-49M
2019-12-31 → 2025-12-31
Net margin-20.7%
2019-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ADPT 5Y avg Peer Median Verdict
P/E (TTM) -70.95Y avg ≈-14.9 ≈-14.9 · ·
P/S (TTM) 14.65Y avg ≈9.9 ≈9.9 4.6 Overvalued
P/B (MRQ) 31.65Y avg ≈5.4 ≈5.4 3.5 Overvalued
EV / EBITDA -77.45Y avg ≈-18.1 ≈-18.1 · ·
Price / FCF (TTM) -187.65Y avg ≈-17.1 ≈-17.1 · ·
Price / Cash Flow (TTM) -214.65Y avg ≈-18.9 ≈-18.9 · ·
EV / Revenue 16.05Y avg ≈6.4 ≈6.4 · ·
EV / FCF -90.35Y avg ≈-22.2 ≈-22.2 · ·
Price / Tangible Book (MRQ) 31.75Y avg ≈10.4 ≈10.4 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 51.3%
Next Report Nov 03, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 3, 2026 $-0.10 $-0.14 26.7%
March 31, 2026 $-0.12 $-0.16 26.5%
Dec. 31, 2025 $-0.09 $-0.18 51.3%
Sept. 30, 2025 $0.06 $-0.15 140.2%
June 30, 2025 $-0.17 $-0.24 30.2%
March 31, 2025 $-0.20 $-0.30 33.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 15
Metric Trend 20252024202320222021202020192018
Revenue $277M$179M$170M$185M$154M$98M$85M$56M
Cost of Revenue $71M$72M$76M$58M$49M$23M$22M$20M
R&D Expense $94M$103M$122M$142M$142M$116M$71M$39M
SG&A Expense $73M$73M$84M$89M$75M$50M$30M$20M
Operating Expenses $334M$342M$397M$385M$363M$251M$163M$105M
Operating Income $-57M$-163M$-227M$-200M$-209M$-153M$-78M$-50M
Interest Expense $12M$12M$14M$4M····
Pretax Income $-59M$-160M$-225M$-200M$-207M$-146M$-69M·
Income Tax $0$0$0···$0·
Net Income $-59M$-159M$-225M$-200M$-207M$-146M$-69M$-46M
EPS (Basic) $-0.39$-1.08$-1.56$-1.40$-1.48$-1.11··
EPS (Diluted) $-0.39$-1.08$-1.56$-1.40$-1.48$-1.11··
Shares (Basic) 151,721,939147,101,648144,383,294142,515,917140,354,915131,216,468··
Shares (Diluted) 151,721,939147,101,648144,383,294142,515,917140,354,915131,216,468··
EBITDA $-57M$-163M$-227M$-200M$-209M$-153M$-78M·
Balance Sheet 27
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $70M$48M$65M$90M$139M$123M$97M$55M
Receivables $50M$42M$38M$40M$17M$10M$13M$5M
Inventory $10M$8M$14M$14M$19M$14M$9M$8M
Prepaid Expense $13M$11M$11M$9M$13M$15M$14M$3M
Current Assets $300M$284M$410M$562M$403M$727M$613M$181M
PP&E (Net) $34M$49M$68M$83M$85M$40M$60M$19M
PP&E (Gross) $130M$136M$141M$138M$121M$64M$78M$32M
Accum. Depreciation $96M$88M$73M$54M$36M$24M$18M$12M
Goodwill $119M$119M$119M$119M$119M$119M$119M$119M
Intangibles $2M$3M$5M$7M$9M$10M$12M$14M
Other Non-current Assets $1M$2M$4M$2M$875.0K$598.0K$784.0K$186.0K
Total Assets $513M$539M$661M$857M$923M$1.12B$912M$333M
Accounts Payable $6M$7M$8M$8M$3M$3M$4M$2M
Accrued Liabilities $8M$8M$9M$12M$9M$13M$4M$3M
Current Liabilities $90M$98M$88M$110M$114M$105M$78M$23M
Capital Leases $70M$79M$89M$99M$107M$104M··
Other Non-current Liabilities $20.0K$20.0K····$93.0K·
Total Liabilities $288M$337M$353M$393M$319M$373M$341M$30M
Long-term Debt $131M$133M······
Total Debt $131M$133M$131M·····
Common Stock $15.0K$14.0K$14.0K$14.0K$14.0K$14.0K$12.0K$1.0K
Paid-in Capital $1.58B$1.51B$1.45B$1.39B$1.32B$1.25B$936M$38M
Retained Earnings $-1.36B$-1.30B$-1.14B$-919M$-719M$-512M$-365M$-296M
AOCI $253.0K$166.0K$215.0K$-4M$-1M$893.0K$671.0K$-107.0K
Stockholders' Equity $219M$203M$308M$464M$604M$743M$571M$-258M
Liabilities + Equity $513M$539M$661M$857M$923M$1.12B$912M$333M
Shares Outstanding 153,779,418147,773,744145,082,271143,105,002141,393,865137,646,896125,238,14212,841,536
Cash Flow 13
Metric Trend 20252024202320222021202020192018
D&A $16M$17M$20M$21M····
Stock-based Comp $51M$54M$63M$55M$43M$25M$13M$11M
Amort. of Intangibles $2M$2M$2M$2M$2M$2M$2M$2M
Restructuring ·$2M·$2M····
Operating Cash Flow $-46M$-95M$-156M$-184M$-193M$-150M$205M$-32M
CapEx $3M$4M$11M$16M$62M$19M$11M$6M
Investing Cash Flow $38M$78M$130M$3M$181M$-117M$-482M$736.0K
Stock Issued ·····$272M$321M·
Net Stock Activity ·····$272M··
Financing Cash Flow $30M$241.0K$2M$132M$27M$294M$320M$1M
Net Change in Cash $22M$-17M$-24M$-49M$16M$27M$44M$-30M
Free Cash Flow $-49M$-99M$-167M$-200M$-254M$-168M$194M·
Levered FCF $-61M·······
Profitability 7
Metric Trend 20252024202320222021202020192018
Operating Margin -20.6%-90.8%-133.3%-108.0%-135.4%-155.3%-92.2%·
Net Margin -21.5%-89.1%-132.3%-108.0%-134.3%-148.6%-80.7%·
Pretax Margin -21.5%-89.2%-132.3%-108.1%-134.3%···
EBITDA Margin -20.6%-90.8%-133.3%-108.0%-135.4%-155.3%-92.2%·
ROA -11.3%-26.6%-29.7%-22.5%-20.3%-14.4%-11.0%·
ROE -28.2%-62.4%-58.3%-37.5%-30.8%-23.0%-11.9%·
ROIC -16.3%·······
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018
Current Ratio 3.32.94.75.13.56.97.8·
Quick Ratio 1.30.91.21.21.41.31.4·
Debt / Equity 0.60.70.4·····
LT Debt / Equity 0.60.70.4·····
Interest Coverage -4.8-14.0-16.5-47.2····
Efficiency 3
Metric Trend 20252024202320222021202020192018
Asset Turnover 0.50.30.20.20.20.10.1·
Inventory Turnover 7.86.35.23.43.01.92.6·
Receivables Turnover 6.04.54.46.411.28.79.7·
Per Share 5
Metric Trend 20252024202320222021202020192018
Book Value / Share $1.42$1.37$2.13$3.24$4.27$5.40$4.56·
Revenue / Share $1.83$1.22$1.18$1.30····
Cash Flow / Share $-0.30$-0.65$-1.08$-1.29····
Cash / Share $0.46$0.32$0.45$0.63$0.98$0.90$0.77·
EPS (TTM) $-0.39$-1.08$-1.56$-1.40$-1.48$-1.11··
Growth Rates 3
Metric Trend 20252024202320222021202020192018
Revenue YoY 54.8%5.1%-8.1%20.1%56.9%···
Revenue CAGR 3Y 14.3%5.1%20.1%·····
Revenue CAGR 5Y 23.0%·······
Valuation (TTM) 14
Metric Trend 20252024202320222021202020192018
Revenue TTM $277M$179M$170M$185M$154M$98M$85M·
Net Income TTM $-59M$-159M$-225M$-200M$-207M$-146M$-69M·
Market Cap $2.50B$886M$711M$1.09B$3.97B$8.14B$3.75B·
Enterprise Value $2.56B$971M$776M·····
P/E -41.6-5.6-3.1-5.5-19.0-53.3··
P/S 9.05.04.25.925.782.744.0·
P/B 11.44.42.32.46.611.06.6·
P / Tangible Book 25.511.03.93.28.313.3··
P / Cash Flow -54.3-9.3-4.5-5.9-20.6-54.418.2·
P / FCF -51.0-9.0-4.3-5.5-15.6-48.319.3·
EV / EBITDA -44.8-6.0-3.4·····
EV / FCF -52.3-9.8-4.6·····
EV / Revenue 9.25.44.6·····
Earnings Yield -2.4%-18.0%-31.8%-18.3%-5.3%-1.9%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $277M $179M $170M $185M $154M
Operating Margin % -20.6% -90.8% -133.3% -108.0% -135.4%
Net Income $-59M $-159M $-225M $-200M $-207M
Diluted EPS $-0.39 $-1.08 $-1.56 $-1.40 $-1.48

Institutional owners (13F) 312 filers · $3.5B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 312
Value held $3.5B
New positions 46
Exited positions 37
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
46 (-11 vs prior Q) 37 (0 vs prior Q) 113 (+14 vs prior Q) 85 (-12 vs prior Q) +17.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VIKING GLOBAL INVESTORS LP $643,365,037 29,993,708 18.50% Shares
BlackRock, Inc. $324,734,962 15,139,159 9.34% Shares
VANGUARD GROUP INC $183,222,148 11,282,152 5.27% Shares
VANGUARD CAPITAL MANAGEMENT LLC $137,356,941 6,403,587 3.95% Shares
WELLINGTON MANAGEMENT GROUP LLP $126,798,802 5,911,366 3.65% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $117,465,155 5,476,231 3.38% Shares
D. E. Shaw & Co., Inc. $99,224,675 4,625,859 2.85% Shares
WESTFIELD CAPITAL MANAGEMENT CO LP $91,540,985 4,267,645 2.63% Shares
GEODE CAPITAL MANAGEMENT, LLC $78,131,203 3,641,837 2.25% Shares
STATE STREET CORP $74,181,636 3,458,388 2.13% Shares
Invesco Ltd. $66,366,535 3,094,011 1.91% Shares
GOLDMAN SACHS GROUP INC $64,011,670 2,984,227 1.84% Shares
UBS Group AG $61,392,474 2,862,120 1.77% Call option
Driehaus Capital Management LLC $54,219,229 2,527,703 1.56% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $54,153,099 2,524,620 1.56% Shares
Nuveen, LLC $50,754,025 2,366,155 1.46% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $46,810,892 2,182,326 1.35% Shares
FRED ALGER MANAGEMENT, LLC $44,879,492 2,092,284 1.29% Shares
ARK Investment Management LLC $44,837,058 2,090,306 1.29% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $42,284,385 1,971,300 1.22% Call option
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $40,523,000 1,889,188 1.17% Shares
Aristotle Atlantic Partners, LLC $39,436,104 1,838,513 1.13% Shares
TORONTO DOMINION BANK $38,610,000 1,800,000 1.11% Call option
BANK OF AMERICA CORP /DE/ $37,109,444 1,730,044 1.07% Shares
JANE STREET GROUP, LLC $34,116,504 1,590,513 0.98% Shares
NORTHERN TRUST CORP $32,332,679 1,507,351 0.93% Shares
Sumitomo Mitsui Trust Group, Inc. $28,525,411 1,329,856 0.82% Shares
Amova Asset Management Americas, Inc. $28,512,113 1,329,856 0.82% Shares
OBERWEIS ASSET MANAGEMENT INC/ $27,000,209 1,258,751 0.78% Shares
PERCEPTIVE ADVISORS LLC $26,111,621 1,217,325 0.75% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25,279,940 1,178,552 0.73% Shares
AMERIPRISE FINANCIAL INC $23,332,376 1,087,754 0.67% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $22,993,006 1,071,935 0.66% Shares
Blue Water Life Science Advisors, LP $21,667,610 1,010,145 0.62% Shares
VANGUARD FIDUCIARY TRUST CO $20,049,508 934,709 0.58% Shares
Aberdeen Group plc $19,712,507 918,998 0.57% Shares
Freestone Grove Partners LP $18,912,208 881,688 0.54% Shares
KENNEDY CAPITAL MANAGEMENT LLC $18,228,103 849,795 0.52% Shares
Connor, Clark & Lunn Investment Management Ltd. $16,857,619 785,903 0.48% Shares
PANAGORA ASSET MANAGEMENT INC $16,679,842 777,615 0.48% Shares
MORGAN STANLEY $16,435,667 766,230 0.47% Shares
Granite Investment Partners, LLC $16,242,305 757,217 0.47% Shares
Trexquant Investment LP $15,792,777 736,260 0.45% Shares
FMR LLC $15,219,503 709,534 0.44% Shares
JENNISON ASSOCIATES LLC $14,718,882 686,195 0.42% Shares
Hillsdale Investment Management Inc. $14,676,454 684,217 0.42% Shares
NEXT CENTURY GROWTH INVESTORS LLC $13,080,853 609,830 0.38% Shares
TUDOR INVESTMENT CORP ET AL $11,657,753 543,485 0.34% Shares
ExodusPoint Capital Management, LP $11,114,232 518,146 0.32% Shares
SEI INVESTMENTS CO $10,935,157 509,797 0.31% Shares

Show all 312 institutional owners →

Company insiders 27 insiders · 17 officers · 10 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Chad M Robins CEO and Chairman Aug. 18, 2026 M 2,180,518 0 19 $-39,801,326
Kyle Piskel Chief Financial Officer May 18, 2026 S 256,725 0 6 $-3,581,681
Tycho Peterson Chief Financial Officer March 5, 2024 S 531,553 0 0 $0
Chad M Cohen Chief Financial Officer Dec. 22, 2021 M 21,604 0 0 $0
Julie Rubinstein President and COO April 27, 2026 M 377,802 0 47 $-13,371,115
Mark R Adams Chief Operating Officer April 11, 2023 S 175,361 0 0 $0
Francis Lo Chief People Officer Sept. 16, 2026 M 220,867 0 15 $-13,213,683
Susan Bobulsky Chief Commercial Officer, MRD Sept. 15, 2026 S 395,794 0 9 $-1,204,076
Harlan S Robins Chief Scientific Officer July 21, 2026 M 812,058 0 17 $-29,647,952
Sharon Benzeno Chief Commercial Ofc Imm Med June 29, 2026 M 221,278 0 6 $-14,690,980
Stacy L Taylor SVP and General Counsel Aug. 22, 2024 S 139,365 0 0 $0
Nitin Sood Chief Commercial Officer, MRD Aug. 8, 2023 S 214,808 0 0 $0
Lance Baldo Chief Medical Officer March 8, 2022 S 17,171 0 0 $0
Jyoti Palaniappan SVP, Diagnostics, T-Detect July 19, 2021 M 9,158 0 0 $0
Henning Thorsen SVP, Commercial Operations May 17, 2021 A 29,061 0 0 $0
Nancy Louise Hill EVP, Operations & Program Mana Jan. 19, 2021 M 10,000 0 0 $0
Charles Sang SVP, External Affairs Dec. 11, 2020 M 0 0 0 $0
Katey Einterz Owen Director Aug. 31, 2026 G 66,100 0 1 $-249,990
Robert Hershberg Director Aug. 18, 2026 M 46,683 0 3 $-1,115,696
Peter M Neupert Director Aug. 17, 2026 M 130,625 0 3 $-3,135,850
Michelle Renee Griffin Director June 25, 2026 M 15,625 0 3 $-2,000,259
Michael J Pellini Director March 4, 2025 A 69,690 0 0 $0
Kevin T Conroy Director March 6, 2023 A 22,968 0 0 $0
Leslie Trigg Director March 6, 2023 A 25,907 0 0 $0
David E. Goel Director Feb. 15, 2021 A 1,504 0 0 $0
Andris A Zoltners Director Feb. 13, 2020 A 3,621,016 0 0 $0
Eric Dobmeier · Feb. 14, 2021 A 1,504 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 35 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
ARKG · ARK ETF Trust 2.57% 1,774,756 NS July 31, 2026 N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST 2.11% 64,619 NS July 31, 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 1.26% 186,189 SH Oct. 2, 2026 Daily
MEDI · Harbor ETF Trust 0.98% 17,855 NS July 31, 2026 N-PORT
BRNY · EA Series Trust 0.57% 147,197 NS July 31, 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.57% 327,285 NS July 31, 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0.29% 11,293 SH Oct. 2, 2026 Daily
IBB · iShares Trust 0.28% 1,179,205 SH Sept. 11, 2026 Daily
FYX · First Trust Exchange-Traded AlphaDE… 0.27% 162,673 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.24% 1,444,121 SH Sept. 11, 2026 Daily
ESSC · Strategy Shares 0.24% 3,763 NS July 31, 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0.19% 165,252 SH Aug. 19, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.14% 42,053 NS July 31, 2026 N-PORT
ISCG · iShares Trust 0.12% 49,206 SH Sept. 11, 2026 Daily
IWM · iShares Trust 0.12% 3,941,006 SH Sept. 11, 2026 Daily
FAD · First Trust Exchange-Traded AlphaDE… 0.12% 29,650 NS July 31, 2026 N-PORT
RSSL · Global X Funds 0.11% 73,784 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.10% 886,884 SH Aug. 19, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.09% 85,150 SH Oct. 2, 2026 Daily
ESML · iShares Trust 0.06% 69,841 SH Sept. 11, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.06% 51,690 SH Aug. 19, 2026 Daily
VBK · VANGUARD INDEX FUNDS 0.04% 1,011,327 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.04% 345,932 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.04% 55,701 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.03% 1,415,247 SH Aug. 19, 2026 Daily
WSML · iShares Trust 0.03% 7,584 SH Sept. 11, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.02% 1,746,783 SH Aug. 19, 2026 Daily
OMFS · Invesco Exchange-Traded Self-Indexe… 0.01% 1,197 SH Oct. 2, 2026 Daily
TILT · FlexShares Trust 0.01% 9,559 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.01% 43,739 SH Sept. 10, 2026 Daily
ITOT · iShares Trust 0.00% 170,690 SH Sept. 11, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 4,835,465 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 12,307 SH Aug. 19, 2026 Daily
ISCB · iShares Trust · 6,963 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 172,353 SH Sept. 11, 2026 Daily

ADPT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 14 analysts BUY
Median target $27.25 -3.9%
5 35.7% Strong Buy
7 50.0% Buy
2 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-09-30

Mean target $27.44 -3.2%

Now Current price $28.35
Low$21.00 Mean$27.44 High$35.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ADPT $2.50B -41.6 54.8% -21.5% -28.2% ·
AVTR $7.82B -14.7 -3.4% -8.1% -8.9% 32.6%
RGEN $9.23B 190.5 16.4% 6.6% 2.4% ·
BRKR $7.17B -314.1 2.1% -0.25% -0.40% 45.9%
BIO · · · · · ·
SHC $5.02B 65.3 5.7% 6.7% 14.0% 55.5%
ALMR · · · · · ·
MRVI · -3.6 -28.3% -70.4% -48.6% 18.3%
FTRE $1.61B -1.6 1.0% -36.2% -171.1% ·
BLFS · -241.8 28.9% · · ·

Latest News Recent headlines mentioning this company

23
Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026 Yahoo Finance · 3 months, 4 weeks ago Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors. Nasdaq · 4 months, 4 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 4, 2026